Market Overview:
The global pharmaceutical contract manufacturing and contract market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for generic drugs, rising number of outsourcing agreements, and growing focus on quality by pharmaceutical companies. In terms of type, the manufacturing segment is expected to dominate the global pharmaceutical contract manufacturing and contract market during the forecast period. This can be attributed to the increasing demand for Contract Manufacturing Organizations (CMOs) by small-medium enterprises (SMEs) and large enterprises.
Product Definition:
Pharmaceutical Contract Manufacturing & Contract is the process of outsourcing the manufacturing of a pharmaceutical product to a third party. The importance of Pharmaceutical Contract Manufacturing & Contract lies in the fact that it can help companies save money and time while also ensuring that high-quality products are delivered to consumers.
Manufacturing:
Manufacturing is the process of converting raw materials into finished products. It includes various steps such as mixing, weighing, measuring, grinding, blending and packaging which are performed to create a final product for further distribution or sale. Manufacturing can be categorized on the basis of various activities such as pharmaceutical manufacturing ( creating drugs), biotechnology manufacturing ( creating biotech products) and contract manufacturing services ( creating medical devices).
Research:
Research and it's usage in pharmaceutical contract manufacturing & contract market is a service that involves research activities carried out to develop new drugs for various diseases. These services are outsourced by drug manufacturers to meet the demand of increasing R&D activities. The main objective of this service is to produce clinical trial ready materials, which can be used by the drug manufacturer in conducting human trials as well as marketing authorization applications with better efficiency and effectiveness.
Application Insights:
The large enterprise segment dominated the global pharmaceutical contract manufacturing and accounted for a revenue share of over 40.0% in 2017. The growth can be attributed to the increasing demand for drugs across the globe coupled with an increase in healthcare expenditure. Moreover, growing government initiatives towards improving public healthcare infrastructure as well as increasing spending on medicines is expected to drive this industry over the forecast period.
For instance, according to WHO, it is estimated that by 2030 nearly 90% of new HIV infections are anticipated to occur in developing countries owing to lack of awareness about safe sex practices and prevention measures such as antiretroviral therapy remains a major challenge faced by these regions globally which may further fuel this industry demand during future years.
Regional Analysis:
Asia Pacific is expected to emerge as the fastest-growing region over the forecast period. The growth of this region can be attributed to factors such as increasing R&D activities, rising healthcare spending by developing countries like China and India, and growing generic drug manufacturing industry in this region. Moreover, Asia Pacific has a competitive edge over other regions due to availability of skilled labor at low cost along with easy access to capital.
Europe pharmaceutical contract manufacturing market is anticipated to grow at a significant rate during the forecast period owing to rise in R&D investments by global players coupled with high purchasing power of consumers in European countries like Germany, UK and Switzerland etc., which are majorly involved in drug development process. In addition these regions are also focusing on new molecule development for treatment of various diseases which will drive growth further.
Growth Factors:
- Increasing demand for generic drugs due to their low cost and efficacy as compared to branded drugs.
- Stringent regulatory environment in developed countries that mandate stringent quality control measures in the pharmaceutical industry.
- Rising incidence of chronic diseases such as cancer, diabetes, and heart diseases which require long-term treatment regimens.
- Growing demand for outsourcing of pharmaceutical manufacturing services by small and medium-sized drug manufacturers due to lack of technical expertise and financial resources.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Contract Manufacturing & Contract Market Research Report
By Type
Manufacturing, Research
By Application
Small Medium Enterprise, Large Enterprise
By Companies
Catalent, Pharmaceutical Product Development LLC, AbbVie, Baxter BioPharma Solutions, Patheon, Grifols International, Dalton Pharma Services, Boehringer Ingelheim Biopharmaceuticals GmBh, Lonza AG., Grifols S.A, Jubilant Life Sciences Limited, QuintilesIMS, Vetter Pharma, Ligand Pharmaceuticals, Inc., Bausch Health, Recipharm AB, Famar Health Care Services, West Pharmaceutical Services, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Contract Manufacturing & Contract Market Report Segments:
The global Pharmaceutical Contract Manufacturing & Contract market is segmented on the basis of:
Types
Manufacturing, Research
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Small Medium Enterprise, Large Enterprise
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Catalent
- Pharmaceutical Product Development LLC
- AbbVie
- Baxter BioPharma Solutions
- Patheon
- Grifols International
- Dalton Pharma Services
- Boehringer Ingelheim Biopharmaceuticals GmBh
- Lonza AG.
- Grifols S.A
- Jubilant Life Sciences Limited
- QuintilesIMS
- Vetter Pharma
- Ligand Pharmaceuticals, Inc.
- Bausch Health
- Recipharm AB
- Famar Health Care Services
- West Pharmaceutical Services, Inc.
Highlights of The Pharmaceutical Contract Manufacturing & Contract Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Manufacturing
- Research
- By Application:
- Small Medium Enterprise
- Large Enterprise
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Contract Manufacturing & Contract Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Pharmaceutical contract manufacturing is a process where pharmaceutical companies outsource the production of their products to third-party manufacturers. This allows them to focus on developing and marketing their products, while the third-party manufacturers handle all the logistics and production aspects of producing these drugs. Contract manufacturing can also refer to a specific type of contract in which pharmaceutical companies outsource certain parts or all of the production process for a particular drug product.
Some of the major companies in the pharmaceutical contract manufacturing & contract market are Catalent, Pharmaceutical Product Development LLC, AbbVie, Baxter BioPharma Solutions, Patheon, Grifols International, Dalton Pharma Services, Boehringer Ingelheim Biopharmaceuticals GmBh, Lonza AG., Grifols S.A, Jubilant Life Sciences Limited, QuintilesIMS, Vetter Pharma, Ligand Pharmaceuticals, Inc., Bausch Health, Recipharm AB, Famar Health Care Services, West Pharmaceutical Services, Inc..
The pharmaceutical contract manufacturing & contract market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pharmaceutical Contract Manufacturing & Contract Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pharmaceutical Contract Manufacturing & Contract Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pharmaceutical Contract Manufacturing & Contract Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pharmaceutical Contract Manufacturing & Contract Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pharmaceutical Contract Manufacturing & Contract Market Size & Forecast, 2018-2028
4.5.1 Pharmaceutical Contract Manufacturing & Contract Market Size and Y-o-Y Growth
4.5.2 Pharmaceutical Contract Manufacturing & Contract Market Absolute $ Opportunity
Chapter 5 Global Pharmaceutical Contract Manufacturing & Contract Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Type
5.2.1 Manufacturing
5.2.2 Research
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pharmaceutical Contract Manufacturing & Contract Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Applications
6.2.1 Small Medium Enterprise
6.2.2 Large Enterprise
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pharmaceutical Contract Manufacturing & Contract Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pharmaceutical Contract Manufacturing & Contract Analysis and Forecast
9.1 Introduction
9.2 North America Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Type
9.6.1 Manufacturing
9.6.2 Research
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Applications
9.10.1 Small Medium Enterprise
9.10.2 Large Enterprise
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pharmaceutical Contract Manufacturing & Contract Analysis and Forecast
10.1 Introduction
10.2 Europe Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Type
10.6.1 Manufacturing
10.6.2 Research
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Applications
10.10.1 Small Medium Enterprise
10.10.2 Large Enterprise
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pharmaceutical Contract Manufacturing & Contract Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Type
11.6.1 Manufacturing
11.6.2 Research
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Applications
11.10.1 Small Medium Enterprise
11.10.2 Large Enterprise
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pharmaceutical Contract Manufacturing & Contract Analysis and Forecast
12.1 Introduction
12.2 Latin America Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Type
12.6.1 Manufacturing
12.6.2 Research
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Applications
12.10.1 Small Medium Enterprise
12.10.2 Large Enterprise
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pharmaceutical Contract Manufacturing & Contract Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Type
13.6.1 Manufacturing
13.6.2 Research
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pharmaceutical Contract Manufacturing & Contract Market Size Forecast by Applications
13.10.1 Small Medium Enterprise
13.10.2 Large Enterprise
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pharmaceutical Contract Manufacturing & Contract Market: Competitive Dashboard
14.2 Global Pharmaceutical Contract Manufacturing & Contract Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Catalent
14.3.2 Pharmaceutical Product Development LLC
14.3.3 AbbVie
14.3.4 Baxter BioPharma Solutions
14.3.5 Patheon
14.3.6 Grifols International
14.3.7 Dalton Pharma Services
14.3.8 Boehringer Ingelheim Biopharmaceuticals GmBh
14.3.9 Lonza AG.
14.3.10 Grifols S.A
14.3.11 Jubilant Life Sciences Limited
14.3.12 QuintilesIMS
14.3.13 Vetter Pharma
14.3.14 Ligand Pharmaceuticals, Inc.
14.3.15 Bausch Health
14.3.16 Recipharm AB
14.3.17 Famar Health Care Services
14.3.18 West Pharmaceutical Services, Inc.
